Quantitation of somatostatin receptor type 2 in neuroendocrine (merkel cell) carcinoma of the skin by competitive RT-PCR

1999 ◽  
Vol 10 (1) ◽  
pp. 37-46 ◽  
Author(s):  
Mauro Papotti ◽  
Luigia Macri’ ◽  
Alberto Pagani ◽  
Filippo Aloi ◽  
Gianni Bussolati
2018 ◽  
Vol 32 (6) ◽  
pp. e236-e237 ◽  
Author(s):  
K.V. Orlova ◽  
V.V. Delektorskaya ◽  
Y.V. Vishnevskaya ◽  
T.T. Kondratieva ◽  
N.F. Orel ◽  
...  

2021 ◽  
pp. 030098582110454
Author(s):  
Soma Ito ◽  
James K. Chambers ◽  
Ayumi Sumi ◽  
Nanako Yamashita-Kawanishi ◽  
Tetsuo Omachi ◽  
...  

Merkel cell carcinoma (MCC) is a cutaneous neuroendocrine tumor. We recently demonstrated that cats with MCC often have other proliferative cutaneous lesions, such as squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Based on this finding, we hypothesize that Felis catus papillomavirus (FcaPV) is involved in the development of MCC in cats, similar to SCC and BCC. To investigate this hypothesis, the presence of FcaPV nucleic acid and immunoreactivity for tumor suppressor proteins were examined in 21 feline MCC cases. Polymerase chain reaction using FcaPV type-specific primers detected FcaPV2 DNA in 20/21 samples of MCC. The complete FcaPV2 sequence was characterized in one case. In situ hybridization for FcaPV2 E7 revealed punctate nuclear signals within tumor cells in 19/21 MCC. Increased immunoreactivity for p16CDKN2A protein and decreased immunoreactivity for retinoblastoma (pRb) and p53 proteins were observed in 20/21 MCC. These results suggest that feline MCC cases are infected with FcaPV2 and the subsequent inhibition of pRb and p53 induced by integrated viral oncogenes is associated with feline MCC tumorigenesis, similar to other PV-induced proliferative cutaneous lesions. On the other hand, the single case of FcaPV2-negative MCC showed strong p53 immunoreactivity, suggesting mutations in p53 caused by cancer inducers other than FcaPV2 infection in this case. The present study suggests FcaPV2 as a cause of feline MCC.


Immunotherapy ◽  
2020 ◽  
Vol 12 (15) ◽  
pp. 1133-1138 ◽  
Author(s):  
Cesar Martins da Costa ◽  
Zenaide Silva de Souza ◽  
Alessandra Corte Real Salgues ◽  
Guilherme Harada ◽  
Pedro Paulo Marino Rodrigues Ayres ◽  
...  

Background: Little is known about the 2019 novel coronavirus disease (COVID-19) course and outcomes in patients receiving immunotherapy. Here we describe a metastatic Merkel cell carcinoma patient with a severe acute respiratory syndrome coronavirus 2 infection while receiving pembrolizumab. Case presentation: A 66-year-old man, with a metastatic Merkel cell carcinoma receiving pembrolizumab, presented with fever. Chest computed tomography (CT) showed pulmonary ground-glass opacities, suggesting viral or immuno-related etiology. On day 7, the patient was hospitalized due to dyspnea and worsening of the radiological findings. Real time polymerase chain reaction (RT-PCR) testing confirmed COVID-19. The patient developed acute respiratory distress syndrome and acute kidney injury. Hydroxychloroquine was administered for 5 days, but discontinued after supraventricular extrasystoles. Clinical improvement allowed the patient’s discharge after 81 days of hospitalization. Conclusion: A careful evaluation of oncologic patients receiving immunotherapy during the COVID-19 pandemic is of utmost importance.


BMC Cancer ◽  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Kristina Buder ◽  
Constantin Lapa ◽  
Michael C Kreissl ◽  
Andreas Schirbel ◽  
Ken Herrmann ◽  
...  

2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
Adrienne Maier ◽  
Sarah Elizabeth Kerut ◽  
Jose S Subauste ◽  
Stephen Curry

Abstract Introduction: Metastasis within another tumor is rare, and exceedingly more rare within a functional adrenal adenoma. Merkel cell carcinoma (MCC) is an aggressive and rare neuroendocrine carcinoma of the skin. We present a patient with history of MCC who presented with an adrenal mass, found to be metastatic MCC within a cortisol-producing adrenal adenoma. Case description: 54 year old male with a history of type 2 diabetes, hypertension, MCC of right thigh, presented for adrenal mass. He was initially evaluated in the ER for severe abdominal pain for 4 days. He had a CT abdomen done, which showed 6cm right adrenal mass with extensive fat and soft tissue component within it. Hounsfield units within solid area measured up to 47 units, and surrounding area measured -3 Hounsfield units. His history was significant for MCC of right thigh, type 2 diabetes, HTN, obesity and OSA. Pathology from MCC resection showed no evidence of invasion and clear margins, but he did have microscopic focus on inguinal lymph node biopsy. His PET scan was negative except for low uptake in a 6cm right adrenal lesion that was considered benign-appearing. He completed radiation therapy to right thigh and groin. Physical exam was notably negative for any cushingoid features. Aldosterone, renin and plasma metanephrines were normal. Cortisol after dexamethasone suppression test was elevated, and ACTH and DHEAS were low, raising suspicion of Cushing’s syndrome. He had right adrenalectomy and was then started on steroid replacement. Pathology showed adrenocortical adenoma with a 2cm well-circumscribed mass within the adenoma positive for metastatic MCC with lymphovascular invasion. ACTH stimulation testing was performed at follow up after holding hydrocortisone for over 24 hours, and was consistent with suppression of glucocorticoid axis in the contralateral adrenal gland. Discussion: MCC and metastasis within a functional adrenal tumor are both rare occurrences. Our patient had positive regional lymph node involvement at the time of diagnosis, and although the initial PET scan was interpreted as showing an benign adrenal adenoma, it is likely that this represented distant metastasis. Labs indicated that the surrounding adenoma was likely cortisol-producing. To our knowledge, this is the first case reported of metastatic MCC within a functional adrenal adenoma. References: Baek, SH, et al. “Merkel cell carcinoma of the Axilla and Adrenal Gland: A Case Report with Imaging and Pathologic Findings.” Case Reports in Medicine. Volume 2015, Article ID 931238. Dongyan, L., S. Kumar. “An exceedingly rare adrenal collision tumor: adrenal adenoma-metastatic breast cancer-myelolipoma.” Journal of Community Hospital Internal Medicine Perspectives, 2017. Vol. 7, No. 4, 241-244. Martin, JT, et al. “Metastatic adenocarcinoma within a functioning adrenal adenoma: a case report.” Cases Journal 2009, 2:7965.


Sign in / Sign up

Export Citation Format

Share Document